Relationship of maternal serum resistin and visfatin levels with gestational diabetes mellitus

References

• Baptiste-Roberts K, Barone BB, Gary TL. Risk factors for type 2 diabetes among women with gestational diabetes: a systematic review. Am J Med 2009;122:207–14
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Gestational diabetes mellitus (Position Statement). Diabetes Care 2004;27:88–90
   PubMed Web of Science ®Google Scholar
• Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862–8
   PubMed Web of Science ®Google Scholar
• Catalano P, Tyzbir ED, Roman NM. Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. Am J Obstet Gynecol 1991;165:1667–72
   PubMed Web of Science ®Google Scholar
• Kafkasli A. Preterm doğum. In: Gabbe SG, Niebyl JR, Simpson JL, eds. Obstetrikte normal ve sorunlu gebelikler. Istanbul: Nobel & Güneş tip kitabevi; 2009:713–32
   Google Scholar
• McTernan PG, Kusminski CM, Kumar S. Resistin. Curr Opin Lipidol 2006;17:170–5
   PubMed Web of Science ®Google Scholar
• Al-Suhaimi EA, Shehzad A. Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity. Eur J Med Res 2013;18:12
   PubMed Web of Science ®Google Scholar
• Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;18:426–30
   Google Scholar
• Chen D, Fang Q, Chai Y, et al. Serum resistin in gestational diabetes mellitus and early postpartum. Clin Endocrinol 2007;67:208–11
   PubMed Web of Science ®Google Scholar
• Skvarca A, Tomazic M, Krhin B, et al. Adipocytokines and insulin resistance across various degrees of glucose tolerance in pregnancy. J Int Med Res 2012;40:583–9
   PubMed Web of Science ®Google Scholar
• Akdeniz N, Kuyumcuoğlu U, Kale A, et al. Resistin may not associate with gestational diabetes mellitus although insulin resistance. Clin Exp Obstet Gynecol 2011;38:236–8
   PubMedGoogle Scholar
• Rezvan N, Hosseinzadeh-Attar MJ, Masoudkabir F, et al. Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy. Arch Gynecol Obstet 2012;285:1257–62
   PubMed Web of Science ®Google Scholar
• Carpenter MW, Coustan DR. Criteria for screening tests forgestational diabetes. Am J Obstet Gynecol 1982;144:768–73
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes – 2011. Diabetes Care 2011;34:S11–61
   PubMed Web of Science ®Google Scholar
• Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307–12
   PubMed Web of Science ®Google Scholar
• Kuzmicki M, Telejko B, Szamatowicz J, et al. High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol 2009;25:258–63
   PubMed Web of Science ®Google Scholar
• Lappas M, Yee K, Permezel M, Rice GE. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol 2005;186:457–65
   PubMed Web of Science ®Google Scholar
• Telejko B, Kuzmicki M, Zonenberg A, et al. Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue. Diabetes Res Clin Pract 2009;84:68–75
   PubMed Web of Science ®Google Scholar
• Chan TF, Yuan SS, Chen HS, et al. Correlations between umbilical and maternal serum adiponectin levels and neonatal birthweights. Acta Obstet Gynecol Scand 2004;83:165–9
   PubMed Web of Science ®Google Scholar
• Wang J, Shang LX, Dong X, et al. Relationship of adiponectin and resistin levels in umbilical serum, maternal serum and placenta with neonatal birthweight. Aust N Z J Obstet Gynaecol 2010;50:432–8
   PubMed Web of Science ®Google Scholar
• Shang LX, Tang QL, Wang J, et al. Relationship of adiponectin and visfatin with fetus intrauterine growth. Zhonghua Fu Chan Ke Za Zhi 2009;44:246–8
   PubMedGoogle Scholar
• Mohamed MH, Gad GI, Ibrahim HY, et al. Cord blood resistin and adiponectin in term newborns of diabetic mothers. Arch Med Sci 2010;6:558–66
   PubMedGoogle Scholar
• Mazaki-Tovi S, Romero R, Kusanovic JP, et al. Maternal visfatin concentration in normal pregnancy. J Perinat Med 2009;37:206–17
   PubMed Web of Science ®Google Scholar
• Lewandowski KC, Stojanovic N, Press M, et al. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 2007;50:1033–7
   PubMed Web of Science ®Google Scholar
• Ferreira AF, Rezende JC, Vaikousi E, et al. Maternal serum visfatin at 11–13 weeks of gestation in gestational diabetes mellitus. Clin Chem 2011;57:609–13
   PubMed Web of Science ®Google Scholar
• Revollo JR, Grimm AA, Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol 2007;23:164–70
   PubMed Web of Science ®Google Scholar